scorecardresearch
Add as a preferred source on Google
Friday, December 19, 2025
TopicCovid vaccine

Topic: Covid vaccine

India’s Covid data like counting potholes under streetlights. There are far more in the dark

The Covid-19 pandemic is both an information problem and a health problem.

Moderna Covid vaccine spurs ‘strong immune response, no serious side-effect’ in older adults

The vaccine, called mRNA-1273, is being developed by Moderna with the US govt's National Institutes of Health. The small study involved 40 adults aged over 56.

Aim to vaccinate 20-25 crore people against Covid by July 2021, says Harsh Vardhan

Vardhan said an expert group is studying all aspects of vaccines and the health ministry is preparing a format in which states will submit lists of priority population groups.

Oxford Covid-19 vaccine could get clearance by Christmas this year, says UK media report

A full vaccine roll-out programme could take six months or less after approval, said UK government sources quoted in the report.

Covid-19 vaccine not likely to be available before end of 2021, shows experts’ survey

Researchers at McGill University in Canada carried out a survey of 28 experts working in vaccinology who said there may be some false starts before an effective vaccine is available.

Oxford vaccine trials running ‘smoothly’ in India, no adverse side-effects so far

In India, trials of the Oxford-AstraZeneca vaccine are being carried out by the Pune-based Serum Institute of India (SII) at 17 sites.

It’ll take more than vaccines to fight Covid, Novartis CEO Narasimhan says

Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.

Cold chains to mobile app — Govt’s to-do list for states, UTs to handle Covid vaccine drives

The health ministry has given states and UTs time till 15 October to submit 'meticulous' plans to handle the vaccine — from storage and transport to distribution.

Serum Institute will deliver 10 crore more doses of Covid vaccine to India, other countries

Pune-based Serum Institute of India has already committed to supplying 10 crore doses of the vaccine at a price of about Rs 225 per dose.

Zee News questions Mamata on Nusrat Jahan controversy, NDTV tracks farmers’ protests

A quick take on what prime time TV news talked about.

On Camera

What the key political events of 2025 tell us about Narendra Modi and India’s future

From Operation Sindoor to India-US tensions to the EC controversies, a clear understanding has emerged about where the politics is headed now.

Antitrust watchdog Competition Commission to probe IndiGo flight disruptions

While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.